Salvona to represent Zschimmer & Schwarz specialty cosmetics products in the US
The companies have entered into a global strategic partnership in an effort to extend each other’s product portfolios while also strengthening their position and service expertise in the US and European cosmetic markets.
Zschimmer & Schwarz, a specialist in chemical auxiliaries for skin and hair care products and already established in Europe, only has one facility in Atlanta and is looking to expand its presence in the US market.
The Germany-based supplier bought a minor stake in Salvona recently as it felt the company's vast profile of contacts and knowledge of the US cosmetics market would help it expand, in turn agreeing to help build up Solvana's presence in the European market.
“The venture aims to strengthen the position and service expertise of both parties,” a Solvana spokesperson told CosmeticsDesign.com USA.
While Dr Martin Haberl of Zchimmer & Schwarz, told this publication that the partnership is “in line with the growth strategy of the company and its desire to diversify and expand its reach in the US.”
Beneficial
The collaboration is also said to bring further investment into Salvonaʼs nanotechnology focused GMP manufacturing capabilities and delivery systems to meet what it says is a growing need for effective and safe dermatological topical solutions.
Its expertise lies in providing a wide range of patents for technologies and applications in personal care across the US and in Asia and, according to a company representitive "hopes to use this expertise to help Z&S in the coming years on the US market."
Strategic partnerships proving successful for brand expansion
Ingredients supplier Lipotec recently increased its US presence by opening a subsidiary as part of it's strategy expansion and commitment to the market.
The Barcelona-based firm has been active in the US cosmetic market for over 20 years after entering into a stratefic partnership with Centerchem, with whom it continues to work closely with.
"We are confident and excited about the possibilities of collaborating on a day-to-day basis with our US customers. We look forward to developing with them specific and exclusive projects" said then CEO Dr Juan Carlos Escudero.
